banner
Reference Listed Drugs
Mirabegron For Extended-release Oral Suspension Reference Listed Drug

Mirabegron For Extended-release Oral Suspension Reference Listed Drug

For R&D purposes only. Mirabegron for Extended-release Oral Suspension activates certain receptors in your bladder that causes your bladder muscles to relax.

Product Details

* Please be kindly noted products are supplied for RLD supplies/ Reference listed drugs/ Comparator Drug Clinical trials. We do not sell to patients.

 

Generic name Mirabegron for Extended-release Oral Suspension
Trade name Myrbetriq Granules
Specification 8mg/ml
Main ingredients Mirabegron
Dosage Form Powder for Suspension, Extended-release
MA Holder Astellas Pharma Global Development, Inc.
Category Reference Listed Drugs (RLDs)

 

Indications:
Mirabegron is used alone or together with other medicines (eg, solifenacin succinate) to treat the symptoms of an overactive bladder (OAB), such as incontinence (loss of bladder control), a strong need to urinate right away, or a frequent need to urinate. It is also used to treat neurogenic detrusor overactivity (NDO). Mirabegron works on the muscles of the bladder to increase the amount of urine your bladder can hold and prevent them from causing incontinence.

 

For more details, pls contact Janney:

Email: tosun-global@upharm.cn

Wechat/Whatsapp:(+86)18922120575

Hot Tags: mirabegron for extended-release oral suspension reference listed drug, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Adefovir Dipivoxil Tablets, AdapaleneGel, Reference Listed Drugs, Olanzapine Tablets, Esomeprazole Magnesium Enteric Coated Capsules, Alfacalcidol Soft Capsules

Send Inquiry
Verification Code: